Evaluation of Serum Markers of Exocrine Pancreatic Function and Pathology in Dogs Presented for Necropsy
World Small Animal Veterinary Association World Congress Proceedings, 2007
J.M. Steiner1; S.J. Newman2; P.G. Xenoulis1; K. Woosley2; J.S. Suchodolski1; D.A. Williams1; L. Barton2
1Gastrointestinal Laboratory, Texas A&M University, College Station, TX, USA; 2The Animal Medical Center, New York, NY, USA

The objective of this study was to evaluate several serum markers of exocrine pancreatic function and pathology in dogs presented for necropsy.

Pancreata were sectioned every 2 cm in 197 dogs presented for necropsy, sections were scored for a variety of lesions, and acute (AI) and chronic (CI) pancreatitis indices were calculated. Serum activities of amylase (AA) and lipase (LA), and concentrations of trypsin-like immunoreactivity (cTLI), pancreatic lipase immunoreactivity (cPLI), and trypsin-α1-proteinase inhibitor complexes were assessed for correlation with AI and CI.

In 147 (74.6%) dogs AI>0 and in 116 (58.9%) CI>0. Overall, cPLI, AA, and LA showed a positive correlation with AI, and cPLI and AA with CI (Spearman r-values: 0.337, 0.208, 0.301, 0.187, and 0.182). Of the 36 dogs (18.3%) without any histopathologic evidence of pancreatic inflammation, 15 (41.7%) had all the serum markers within the reference range.

Serum cPLI and AA showed a positive correlation with both AI and CI. However, several of the 36 dogs without histopathological evidence of pancreatic inflammation had serum markers above the reference ranges. Previous studies suggest that lack of specificity is an unlikely explanation for these observations. Pancreatic inflammation could have been missed due to patchy distribution of lesions and further histopathologic studies evaluating 1-cm slices did reveal additional lesions. Finally, in some dogs, blood had been collected shortly after death. Post mortem leakage of pancreatic enzymes, unrelated to pancreatic inflammation, may have occurred in these patients. Further studies are required to confirm this hypothesis and determine it's clinical implications.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Joerg Steiner
Gastrointestinal Laboratory at Texas A&M University
Texas, USA


MAIN : Abstracts - Oral : Exocrine Pancreatic Function
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27